TransMedics' Technology Poised To Transform Underpenetrated $8B Organ Transplant Market, Analyst Expects 22% Upside [Yahoo! Finance]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
The company has developed the Organ Care System (OCS), which is designed to better preserve, assess, and maintain donor organs. Needham notes that TransMedics' OCS technology, backed by extensive clinical data and multiple FDA approvals, is transforming the underpenetrated organ transplant market, which is over $8 billion and has less than 6% penetration. Also Read: This MedTech Company Has Market Expansion Opportunity, Says Bullish Analyst The company's National OCS Program (NOP), a turnkey organ procurement service, has been a significant growth driver. TransMedics has its planes, a staff of surgeons and clinical specialists, and a logistics team that enables transplant centers to procure and transplant more organs. Needham notes that NOP is driving the increasing use of OCS, and TransMedics' revenue growth accelerated from 18% in 2021 before NOP to 209% in 2022 after NOP. TransMedics is projected to become profitable in 2024, and operating margin, EPS, and cash flow ar
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- An Intrinsic Calculation For TransMedics Group, Inc. (NASDAQ:TMDX) Suggests It's 49% Undervalued [Yahoo! Finance]Yahoo! Finance
- Why Shares of TransMedics Stock Plunged This Week [Yahoo! Finance]Yahoo! Finance
- Here's Why TransMedics Group (TMDX) Rose in Q2 [Yahoo! Finance]Yahoo! Finance
- TransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferencePR Newswire
- TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $208.00 price target on the stock.MarketBeat
TMDX
Earnings
- 7/31/24 - Beat
TMDX
Sec Filings
- 9/17/24 - Form 4
- 9/17/24 - Form 4
- 9/11/24 - Form 8-K
- TMDX's page on the SEC website